Nov 29, 2022 / 04:10PM GMT
Derek Robertson - Piper Sandler - Specialist
Good morning. My name is Derek Robertson. (Inaudible) as Specialist at Piper Sandler. My pleasure to introduce Galera Therapeutics, ticker GRTX. Galera is preparing to file the NDA for (inaudible) for the prevention of radiotherapy induced severe oral mucositis by year end, along with a number of other exciting oncology programs. Here to present the company is Dr. Mel Sorensen, President and CEO.
Mel Sorensen - Galera Therapeutics Inc. - President & CEO
Thank you, Derek. Galera's mission is to transform radiotherapy. I'm going to talk about our technology and give you an update on where things are at.
This slide is just a reminder of the forward-looking statements I'll be making. radiation therapy is a key modality for cancer treatment. Of the 1.9 million new cancers annually in the US, over 50% will receive radiation at some part of their treatment. And there are two forms of radiation therapy, external beam radiation therapy, IMRT or intensity modulated radiation therapy, and stereotactic body radiation
Galera Therapeutics Inc at Piper Sandler Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers